Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

MicroRNA-193a Regulates the Transdifferentiation of Human Parietal Epithelial Cells toward a Podocyte Phenotype.

Kietzmann L, Guhr SS, Meyer TN, Ni L, Sachs M, Panzer U, Stahl RA, Saleem MA, Kerjaschki D, Gebeshuber CA, Meyer-Schwesinger C.

J Am Soc Nephrol. 2015 Jun;26(6):1389-401. doi: 10.1681/ASN.2014020190. Epub 2014 Sep 30.

2.

Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases.

Beeken M, Lindenmeyer MT, Blattner SM, Radón V, Oh J, Meyer TN, Hildebrand D, Schlüter H, Reinicke AT, Knop JH, Vivekanandan-Giri A, Münster S, Sachs M, Wiech T, Pennathur S, Cohen CD, Kretzler M, Stahl RA, Meyer-Schwesinger C.

J Am Soc Nephrol. 2014 Nov;25(11):2511-25. doi: 10.1681/ASN.2013050522. Epub 2014 Apr 10.

3.

UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.

Lohmann F, Sachs M, Meyer TN, Sievert H, Lindenmeyer MT, Wiech T, Cohen CD, Balabanov S, Stahl RA, Meyer-Schwesinger C.

Biochim Biophys Acta. 2014 Jul;1842(7):945-58. doi: 10.1016/j.bbadis.2014.02.011. Epub 2014 Feb 28.

4.

Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.

Braune SA, Wichmann D, von Heinz MC, Nierhaus A, Becker H, Meyer TN, Meyer GP, Müller-Schulz M, Fricke J, de Weerth A, Hoepker WW, Fiehler J, Magnus T, Gerloff C, Panzer U, Stahl RA, Wegscheider K, Kluge S.

Crit Care Med. 2013 Jul;41(7):1702-10. doi: 10.1097/CCM.0b013e31828a24a8.

PMID:
23660733
5.

The expression of podocyte-specific proteins in parietal epithelial cells is regulated by protein degradation.

Guhr SS, Sachs M, Wegner A, Becker JU, Meyer TN, Kietzmann L, Schlossarek S, Carrier L, Braig M, Jat PS, Stahl RA, Meyer-Schwesinger C.

Kidney Int. 2013 Sep;84(3):532-44. doi: 10.1038/ki.2013.115. Epub 2013 Apr 24.

6.

Jael syndrome: removal of a knife blade impacted in the maxillofacial region under local anaesthesia.

Dominguete PR, Matos BF, Meyer TN, Oliveira LR.

BMJ Case Rep. 2013 Apr 10;2013. pii: bcr-2013-008839. doi: 10.1136/bcr-2013-008839. Review.

7.

Central nervous system involvement in adults with epidemic hemolytic uremic syndrome.

Wengenroth M, Hoeltje J, Repenthin J, Meyer TN, Bonk F, Becker H, Faiss S, Stammel O, Urban PP, Bruening R.

AJNR Am J Neuroradiol. 2013 May;34(5):1016-21, S1. doi: 10.3174/ajnr.A3336. Epub 2013 Jan 10.

8.

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.

Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nürnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R; Collaborators of the DGfN STEC-HUS registry.

Nephrol Dial Transplant. 2012 Oct;27(10):3807-15. doi: 10.1093/ndt/gfs394.

PMID:
23114903
9.

Report of a case of solitary fibrous tumour of the orbit.

Meyer TN, Matos BH, Oliveira LR, Mendonça AT.

Oral Maxillofac Surg. 2013 Sep;17(3):225-7. doi: 10.1007/s10006-012-0366-1. Epub 2012 Oct 16.

PMID:
23070518
10.

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.

Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmüller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Münte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schöcklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhöner P, Wiesner M, Zeissig S, Büning J, Schiffer M, Kuehbacher T; EHEC-HUS consortium.

BMJ. 2012 Jul 19;345:e4565. doi: 10.1136/bmj.e4565.

11.

Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.

Meyer-Schwesinger C, Dehde S, Sachs M, Mathey S, Arefi K, Gatzemeier S, Balabanov S, Becker JU, Thaiss F, Meyer TN.

Am J Physiol Renal Physiol. 2012 Oct;303(7):F1015-25. doi: 10.1152/ajprenal.00380.2011. Epub 2012 Jul 18.

12.

[Clinical symptoms, treatment and outcome of EHEC and EHEC-HUS patients treated as in-patients].

Dücker C, Dautel P, Wagner K, Przewozna J, Oehlerking S, Repenthin J, Brüning R, Meyer TN, Faiss S.

Dtsch Med Wochenschr. 2011 Sep;136(36):1770-6. doi: 10.1055/s-0031-1286099. Epub 2011 Aug 31. German.

PMID:
21882131
13.

Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis.

Meyer-Schwesinger C, Dehde S, Klug P, Becker JU, Mathey S, Arefi K, Balabanov S, Venz S, Endlich KH, Pekna M, Gessner JE, Thaiss F, Meyer TN.

J Immunol. 2011 Sep 15;187(6):3218-29. doi: 10.4049/jimmunol.1003451. Epub 2011 Aug 15.

14.

Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.

Meyer-Schwesinger C, Meyer TN, Sievert H, Hoxha E, Sachs M, Klupp EM, Münster S, Balabanov S, Carrier L, Helmchen U, Thaiss F, Stahl RA.

Am J Pathol. 2011 May;178(5):2044-57. doi: 10.1016/j.ajpath.2011.01.017.

15.

Epidemiologic profile and quality of life of patients treated for oral cancer in Juiz de Fora, Minas Gerais, Brazil.

de-Jesus RR, Meyer TN, Leite IC, Pereira AA, Armond MC.

Med Oral Patol Oral Cir Bucal. 2010 Jan 1;15(1):e20-4.

16.

CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.

Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.

J Immunol. 2009 Oct 1;183(7):4693-704. doi: 10.4049/jimmunol.0802626. Epub 2009 Sep 4.

17.

Alterations of the podocyte proteome in response to high glucose concentrations.

Schordan S, Schordan E, Endlich N, Lindenmeyer MT, Meyer-Schwesinger C, Meyer TN, Giebel J, Cohen CD, Endlich K, Maurer MH.

Proteomics. 2009 Oct;9(19):4519-28. doi: 10.1002/pmic.200800214.

PMID:
19688724
18.

Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases.

Panzer U, Steinmetz OM, Turner JE, Meyer-Schwesinger C, von Ruffer C, Meyer TN, Zahner G, Gómez-Guerrero C, Schmid RM, Helmchen U, Moeckel GW, Wolf G, Stahl RA, Thaiss F.

Am J Physiol Renal Physiol. 2009 Aug;297(2):F429-39. doi: 10.1152/ajprenal.90435.2008. Epub 2009 May 20.

19.

Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-kappaB p65 signaling.

Meyer-Schwesinger C, Dehde S, von Ruffer C, Gatzemeier S, Klug P, Wenzel UO, Stahl RA, Thaiss F, Meyer TN.

Am J Physiol Renal Physiol. 2009 May;296(5):F1088-99. doi: 10.1152/ajprenal.90746.2008. Epub 2009 Feb 18.

20.

Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier.

Pawar RD, Castrezana-Lopez L, Allam R, Kulkarni OP, Segerer S, Radomska E, Meyer TN, Schwesinger CM, Akis N, Gröne HJ, Anders HJ.

Immunology. 2009 Sep;128(1 Suppl):e206-21. doi: 10.1111/j.1365-2567.2008.02948.x. Epub 2008 Oct 24.

21.

A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies.

Meyer-Schwesinger C, Meyer TN, Münster S, Klug P, Saleem M, Helmchen U, Stahl RA.

J Pathol. 2009 Feb;217(3):452-64. doi: 10.1002/path.2446.

PMID:
18985619
22.

Immediate versus long-term effect of rituximab in recurrent focal segmental glomerulosclerosis.

Meyer TN, Thaiss F, Stahl RA.

Transpl Int. 2008 Nov;21(11):1102. doi: 10.1111/j.1432-2277.2008.00718.x. Epub 2008 Jun 18. No abstract available.

23.

Juvenile ossifying fibroma of the jaw.

Dominguete PR, Meyer TN, Alves FA, Bittencourt WS.

Br J Oral Maxillofac Surg. 2008 Sep;46(6):480-1. doi: 10.1016/j.bjoms.2007.11.007. Epub 2008 Feb 21.

PMID:
18206279
24.
25.

A new mouse model of immune-mediated podocyte injury.

Meyer TN, Schwesinger C, Wahlefeld J, Dehde S, Kerjaschki D, Becker JU, Stahl RA, Thaiss F.

Kidney Int. 2007 Oct;72(7):841-52. Epub 2007 Jul 25.

27.

Rho kinase acts at separate steps in ureteric bud and metanephric mesenchyme morphogenesis during kidney development.

Meyer TN, Schwesinger C, Sampogna RV, Vaughn DA, Stuart RO, Steer DL, Bush KT, Nigam SK.

Differentiation. 2006 Dec;74(9-10):638-47.

PMID:
17177859
28.
29.

Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.

Panzer U, Steinmetz OM, Reinking RR, Meyer TN, Fehr S, Schneider A, Zahner G, Wolf G, Helmchen U, Schaerli P, Stahl RA, Thaiss F.

J Am Soc Nephrol. 2006 Feb;17(2):454-64. Epub 2005 Dec 28.

30.

Tankyrase-1 overexpression reduces genotoxin-induced cell death by inhibiting PARP1.

Yeh TY, Sbodio JI, Nguyen MT, Meyer TN, Lee RM, Chi NW.

Mol Cell Biochem. 2005 Aug;276(1-2):183-92.

PMID:
16132700
31.

An expensive multifactorial renal failure.

Wolf G, Meyer TN, Baumann-Schölzke J, Stahl RA.

Nephrol Dial Transplant. 2004 Nov;19(11):2921-2. No abstract available.

PMID:
15496570
32.

Spatiotemporal regulation of morphogenetic molecules during in vitro branching of the isolated ureteric bud: toward a model of branching through budding in the developing kidney.

Meyer TN, Schwesinger C, Bush KT, Stuart RO, Rose DW, Shah MM, Vaughn DA, Steer DL, Nigam SK.

Dev Biol. 2004 Nov 1;275(1):44-67.

33.

Tunicamycin preserves intercellular junctions, cytoarchitecture, and cell-substratum interactions in ATP-depleted epithelial cells.

George SK, Meyer TN, Abdeen O, Bush KT, Nigam SK.

Biochem Biophys Res Commun. 2004 Sep 10;322(1):223-31.

PMID:
15313195
34.

Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney.

Steer DL, Shah MM, Bush KT, Stuart RO, Sampogna RV, Meyer TN, Schwesinger C, Bai X, Esko JD, Nigam SK.

Dev Biol. 2004 Aug 15;272(2):310-27.

PMID:
15282150
35.

TGF-beta superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud.

Bush KT, Sakurai H, Steer DL, Leonard MO, Sampogna RV, Meyer TN, Schwesinger C, Qiao J, Nigam SK.

Dev Biol. 2004 Feb 15;266(2):285-98.

36.

Galpha12 regulates epithelial cell junctions through Src tyrosine kinases.

Meyer TN, Hunt J, Schwesinger C, Denker BM.

Am J Physiol Cell Physiol. 2003 Nov;285(5):C1281-93. Epub 2003 Jul 30.

37.

A strategy for in vitro propagation of rat nephrons.

Steer DL, Bush KT, Meyer TN, Schwesinger C, Nigam SK.

Kidney Int. 2002 Dec;62(6):1958-65.

39.

Inferiorly based dermal glandular flap.

Meyer TN.

Plast Reconstr Surg. 2002 May;109(6):2155-6; author reply 2156. No abstract available.

PMID:
11994633
40.

Decompression of the common peroneal nerve: experience with 20 consecutive cases.

Meyer TN, Thoma A, Fawcett S, Ginty M, Veltry K.

Plast Reconstr Surg. 2002 Apr 15;109(5):1755-6; author reply 1756. No abstract available.

PMID:
11932644
41.

The nasolabial flap for nasal lining defects.

Meyer TN.

Plast Reconstr Surg. 2002 Jan;109(1):400. No abstract available.

PMID:
11786853
42.

Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity.

Meyer TN, Schwesinger C, Ye J, Denker BM, Nigam SK.

J Biol Chem. 2001 Jun 22;276(25):22048-55. Epub 2001 Apr 9.

43.

Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.

Schwesinger C, Yee C, Rohan RM, Joussen AM, Fernandez A, Meyer TN, Poulaki V, Ma JJ, Redmond TM, Liu S, Adamis AP, D'Amato RJ.

Am J Pathol. 2001 Mar;158(3):1161-72.

44.

Universal ailments.

Meyer TN.

Plast Reconstr Surg. 2001 Jan;107(1):296-7. No abstract available.

PMID:
11228637
45.

Heat shock response reduces mortality after severe experimental burns.

Meyer TN, da Silva AL, Vieira EC, Alves AC.

Burns. 2000 May;26(3):233-8.

PMID:
10741588
46.

Treatment for plantar ulcers in Hansen's disease.

Meyer TN.

Plast Reconstr Surg. 1999 Nov;104(6):1938. No abstract available.

PMID:
10541209
47.

[Cell response to stress].

Meyer TN, da Silva AL.

Rev Assoc Med Bras (1992). 1999 Apr-Jun;45(2):181-8. Review. Portuguese. No abstract available.

PMID:
10413924
48.

Hydrogen peroxide activates ion currents in rat mesangial cells.

Gloy J, Fischer KG, Meyer TN, Schollmeyer P, Greger R, Pavenstädt H.

Kidney Int. 1999 Jul;56(1):181-9.

49.

Breast reduction under local anesthesia.

Meyer TN.

Plast Reconstr Surg. 1998 Feb;101(2):553. No abstract available.

PMID:
9462812
50.

When the surgeon is gloved and the patient needs more local anesthesia.

Meyer TN.

Plast Reconstr Surg. 1996 Nov;98(6):1114. No abstract available.

PMID:
8911491

Supplemental Content

Loading ...
Support Center